Dr. John W. Ames, MD

Dr. Ames practices at Long Island Jewish Medical Center in New Hyde Park, New York.

Dr. Ames' NPI, 1952352072, was assigned on May 13, 2006. Dr. Ames graduated from George Washington University School of Medicine and Health Sciences in 1987. Dr. Ames holds New York license 212527.

Dr. Ames' primary practice is Long Island Jewish Medical Center, at 27005 76th Ave, New Hyde Park, NY 11040 in Nassau County. The practice phone is (516) 876-6000.

Dr. Ames' primary practice is Long Island Jewish Medical Center in New Hyde Park, New York. Dr. Ames is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Ames to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ames practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Ames' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Ames is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Ames' licenses on file in 3 states: New York, Maryland and Pennsylvania.

Dmand AI lists breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation, pancreatic cancer radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Ames treats.

CMS data shows 2,246 Medicare services from Dr. Ames across 21 procedure codes in 2024, for 272 Medicare patients. Medicare paid $149,873 for them. Every service was in an office.

CMS counts 272 Medicare patients who saw Dr. Ames in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ames' median patient age at 72, with 45% women.

In 2024, Dr. Ames wrote 99 Medicare Part D claims for 38 patients. 88% of them were for generic drugs. CMS names the drug for 41 of them, across 1 drug with 11 or more claims each, at $317 in total drug cost. In 2023, CMS named 35 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Ames for performance year 2024, reported through an alternative payment model (APM). Dr. Ames accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ames as offering telehealth.

Dmand AI links 1 paper to Dr. Ames in 2021. Dr. Ames' most frequent co-authors are Maged Mofied Ghaly, MD, Daniel J. Ma, MD and Bhupesh Parashar, MD.

Dmand AI links Dr. Ames to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 3 general payments to Dr. Ames from 3 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. INSYS Therapeutics Inc paid the most, $125.

Dmand AI lists 1 award for Dr. Ames, most recently CMS Stage 1 EHR in 2013.

Dr. Ames graduated from George Washington University School of Medicine and Health Sciences in 1987. Dr. Ames is a member of ASTRO.

Dr. Ames is in network with 14 carriers, including Aetna, MVP Health Care and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.